All Updates

Following is a statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN), on the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing today on the state of tobacco regulation by the Food & Drug Administration (FDA).

An article posted today in the New England Journal of Medicine confirms what public health advocates have suspected for decades that chemicals used to flavor popular candies and drinks are strikingly similar to those used to flavor tobacco products that are designed to addict kids.

Today 's Senate Special Committee on Aging hearing on the fight against cancer represents the first time in more than five years that Congress has focused specific attention on a disease expected to kill more than 585,000 people in America and cost the economy an estimated $216 billion this year.

The information issued today provides much-needed clarity to plans and insurers on what constitutes a comprehensive tobacco cessation benefit under the Affordable Care Act. The ACA requires most health plans to cover tobacco cessation services at no cost to the enrolle, but implementation of this benefit has been inconsistent. Smokers

American Cancer Society Chief Cancer Control Officer Richard Wender, M.D., testified at the Centers for Medicare & Medicaid Services Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) meeting today encouraging the agency to include Low Dose Computed Tomography (LDCT) scans for lung cancer screening among Medicare 's covered services for high risk-groups.

WASHINGTON, D.C. April 28, 2014 The American Cancer Society Cancer Action Network (ACS CAN) submitted comments to the Drug Enforcement Administration (DEA) today in opposition to the agency 's proposal to restrict access to hydrocodone combination products (HCPs). Changing the classification of these pain medications would increase controls over the